Skip to main content
NCBI home page
Sarcoma logoLink to Sarcoma
. 2003 Sep-Dec;7(3-4):159–165. doi: 10.1080/13577140310001650321

Factors Influencing Prognosis After Initial Inadequate Excision (IIE) for Soft Tissue Sarcoma

Albert N Van Geel 1,✉, Alexander M M Eggermont 1, Patrick E J Hanssens 2, Paul I M Schmitz 3
PMCID: PMC2395531  PMID: 18521381

Abstract

Purpose. The influence of initial inadequate excision (IIE) of soft tissue sarcoma (STS) on local control and overall survival is not well established. It is generally believed that an IIE may have a negative impact on both, despite subsequent treatment by radical surgery and radiotherapy. However, data on local recurrence-free survival/overall survival are conflicting and there are no data on the effect of IIE on overall survival.

Patients and methods. A retrospective analysis was made of 86 patients with soft tissue sarcoma of the extremities and trunk after an IIE had been performed due to inappropriate work-up. The minimal follow-up was 7 years. Specimens of the subsequent radical resection were evaluated for residual tumor, grade of tumor and complications of IIE. Endpoints were recurrence-free survival and overall survival.

Results. Specimens of the subsequent radical resection showed residual tumor in 66 patients (77%). The most common complication after IIE was hematoma. In both univariate and multivariate analyses, grade II/III tumors and complications after IIE are significant negative prognostic factors for local recurrence-free survival (P = 0.008 and P = 0.002, respectively, in the Cox model). For this survival, three prognostic groups could be formed based on grade, or presence or absence of complications. Adjuvant radiotherapy did not change the rate of local recurrence-free survival. For overall survival, only tumor grade is a significant factor (log-rank test).

Conclusion. This retrospective study shows that complications associated with an IIE have a significant negative effect on local control, but not on overall survival, because IIE is often the result of inappropriate work-up before surgery. For better diagnosis and therapy STS should be treated in specialized centers.

Full Text

The Full Text of this article is available as a PDF (97.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beck M., Woo A., Leunig M., Ganz R. Gluteus minimus-induced femoral head deformation in dysplasia of the hip. Acta Orthop Scand. 2001 Feb;72(1):13–17. doi: 10.1080/000164701753606626. [DOI] [PubMed] [Google Scholar]
  2. Coindre J. M., Terrier P., Bui N. B., Bonichon F., Collin F., Le Doussal V., Mandard A. M., Vilain M. O., Jacquemier J., Duplay H. Prognostic factors in adult patients with locally controlled soft tissue sarcoma. A study of 546 patients from the French Federation of Cancer Centers Sarcoma Group. J Clin Oncol. 1996 Mar;14(3):869–877. doi: 10.1200/JCO.1996.14.3.869. [DOI] [PubMed] [Google Scholar]
  3. Collin C., Hadju S. I., Godbold J., Shiu M. H., Hilaris B. I., Brennan M. F. Localized, operable soft tissue sarcoma of the lower extremity. Arch Surg. 1986 Dec;121(12):1425–1433. doi: 10.1001/archsurg.1986.01400120075013. [DOI] [PubMed] [Google Scholar]
  4. Eggermont A. M., Schraffordt Koops H., Klausner J. M., Kroon B. B., Schlag P. M., Liénard D., van Geel A. N., Hoekstra H. J., Meller I., Nieweg O. E. Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas. The cumulative multicenter European experience. Ann Surg. 1996 Dec;224(6):756–765. doi: 10.1097/00000658-199612000-00011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Eilber F. R., Giuliano A. E., Huth J. F., Morton D. L. A randomized prospective trial using postoperative adjuvant chemotherapy (adriamycin) in high-grade extremity soft-tissue sarcoma. Am J Clin Oncol. 1988 Feb;11(1):39–45. doi: 10.1097/00000421-198802000-00009. [DOI] [PubMed] [Google Scholar]
  6. Giuliano A. E., Eilber F. R. The rationale for planned reoperation after unplanned total excision of soft-tissue sarcomas. J Clin Oncol. 1985 Oct;3(10):1344–1348. doi: 10.1200/JCO.1985.3.10.1344. [DOI] [PubMed] [Google Scholar]
  7. Goodlad J. R., Fletcher C. D., Smith M. A. Surgical resection of primary soft-tissue sarcoma. Incidence of residual tumour in 95 patients needing re-excision after local resection. J Bone Joint Surg Br. 1996 Jul;78(4):658–661. [PubMed] [Google Scholar]
  8. Gustafson P., Röser B., Rydholm A. Is local recurrence of minor importance for metastases in soft tissue sarcoma? Cancer. 1991 Apr 15;67(8):2083–2086. doi: 10.1002/1097-0142(19910415)67:8<2083::aid-cncr2820670813>3.0.co;2-5. [DOI] [PubMed] [Google Scholar]
  9. Heslin M. J., Lewis J. J., Woodruff J. M., Brennan M. F. Core needle biopsy for diagnosis of extremity soft tissue sarcoma. Ann Surg Oncol. 1997 Jul-Aug;4(5):425–431. doi: 10.1007/BF02305557. [DOI] [PubMed] [Google Scholar]
  10. Hoeber I., Spillane A. J., Fisher C., Thomas J. M. Accuracy of biopsy techniques for limb and limb girdle soft tissue tumors. Ann Surg Oncol. 2001 Jan-Feb;8(1):80–87. doi: 10.1007/s10434-001-0080-y. [DOI] [PubMed] [Google Scholar]
  11. Lewis J. J., Brennan M. F. Soft tissue sarcomas. Curr Probl Surg. 1996 Oct;33(10):817–872. [PubMed] [Google Scholar]
  12. Mankin H. J., Lange T. A., Spanier S. S. The hazards of biopsy in patients with malignant primary bone and soft-tissue tumors. J Bone Joint Surg Am. 1982 Oct;64(8):1121–1127. [PubMed] [Google Scholar]
  13. Mankin H. J., Mankin C. J., Simon M. A. The hazards of the biopsy, revisited. Members of the Musculoskeletal Tumor Society. J Bone Joint Surg Am. 1996 May;78(5):656–663. doi: 10.2106/00004623-199605000-00004. [DOI] [PubMed] [Google Scholar]
  14. Markhede G., Angervall L., Stener B. A multivariate analysis of the prognosis after surgical treatment of malignant soft-tissue tumors. Cancer. 1982 Apr 15;49(8):1721–1733. doi: 10.1002/1097-0142(19820415)49:8<1721::aid-cncr2820490832>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  15. Noria S., Davis A., Kandel R., Levesque J., O'Sullivan B., Wunder J., Bell R. Residual disease following unplanned excision of soft-tissue sarcoma of an extremity. J Bone Joint Surg Am. 1996 May;78(5):650–655. doi: 10.2106/00004623-199605000-00003. [DOI] [PubMed] [Google Scholar]
  16. Pisters P. W., Harrison L. B., Leung D. H., Woodruff J. M., Casper E. S., Brennan M. F. Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma. J Clin Oncol. 1996 Mar;14(3):859–868. doi: 10.1200/JCO.1996.14.3.859. [DOI] [PubMed] [Google Scholar]
  17. Pisters P. W., Leung D. H., Woodruff J., Shi W., Brennan M. F. Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol. 1996 May;14(5):1679–1689. doi: 10.1200/JCO.1996.14.5.1679. [DOI] [PubMed] [Google Scholar]
  18. Rosenberg S. A., Tepper J., Glatstein E., Costa J., Baker A., Brennan M., DeMoss E. V., Seipp C., Sindelar W. F., Sugarbaker P. The treatment of soft-tissue sarcomas of the extremities: prospective randomized evaluations of (1) limb-sparing surgery plus radiation therapy compared with amputation and (2) the role of adjuvant chemotherapy. Ann Surg. 1982 Sep;196(3):305–315. doi: 10.1097/00000658-198209000-00009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Rydholm A., Gustafson P., Röser B., Willén H., Akerman M., Herrlin K., Alvegård T. Limb-sparing surgery without radiotherapy based on anatomic location of soft tissue sarcoma. J Clin Oncol. 1991 Oct;9(10):1757–1765. doi: 10.1200/JCO.1991.9.10.1757. [DOI] [PubMed] [Google Scholar]
  20. Rydholm A., Röser B. Surgical margins for soft-tissue sarcoma. J Bone Joint Surg Am. 1987 Sep;69(7):1074–1078. [PubMed] [Google Scholar]
  21. Shiu M. H., Castro E. B., Hajdu S. I., Fortner J. G. Surgical treatment of 297 soft tissue sarcomas of the lower extremity. Ann Surg. 1975 Nov;182(5):597–602. doi: 10.1097/00000658-197511000-00011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Simon M. A. Biopsy of musculoskeletal tumors. J Bone Joint Surg Am. 1982 Oct;64(8):1253–1257. [PubMed] [Google Scholar]
  23. Spiro I. J., Gebhardt M. C., Jennings L. C., Mankin H. J., Harmon D. C., Suit H. D. Prognostic factors for local control of sarcomas of the soft tissues managed by radiation and surgery. Semin Oncol. 1997 Oct;24(5):540–546. [PubMed] [Google Scholar]
  24. Stotter A. T., A'Hern R. P., Fisher C., Mott A. F., Fallowfield M. E., Westbury G. The influence of local recurrence of extremity soft tissue sarcoma on metastasis and survival. Cancer. 1990 Mar 1;65(5):1119–1129. doi: 10.1002/1097-0142(19900301)65:5<1119::aid-cncr2820650515>3.0.co;2-p. [DOI] [PubMed] [Google Scholar]
  25. Suit H. D., Tepper J. E. Impact of improved local control on survival in patients with soft tissue sarcoma. Int J Radiat Oncol Biol Phys. 1986 Apr;12(4):699–700. doi: 10.1016/0360-3016(86)90083-0. [DOI] [PubMed] [Google Scholar]
  26. Trovik C. S., Bauer H. C., Alvegård T. A., Anderson H., Blomqvist C., Berlin O., Gustafson P., Saeter G., Wallöe A. Surgical margins, local recurrence and metastasis in soft tissue sarcomas: 559 surgically-treated patients from the Scandinavian Sarcoma Group Register. Eur J Cancer. 2000 Apr;36(6):710–716. doi: 10.1016/s0959-8049(99)00287-7. [DOI] [PubMed] [Google Scholar]
  27. Van Geel A. N., Van Unnik J. A., Keus R. B. Diagnosis and treatment of soft tissue tumours: the dutch nationwide-accepted consensus. Sarcoma. 1998;2(3-4):183–191. doi: 10.1080/13577149877957. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Yasko A. W., Reece G. P., Gillis T. A., Pollock R. E. Limb-salvage strategies to optimize quality of life: the M.D. Anderson Cancer Center experience. CA Cancer J Clin. 1997 Jul-Aug;47(4):226–238. doi: 10.3322/canjclin.47.4.226. [DOI] [PubMed] [Google Scholar]

Articles from Sarcoma are provided here courtesy of Wiley

RESOURCES